Osobní účet
Osobní účet
Valneva
Pharmaceutical company developing prophylactic vaccines to treat infectious diseases
Stránky společnostiRok založení
2013
Uzávěrka
7/1/2021
Ziskovost
1.86%
O společnosti
Total Funding
$577.1M
Valneva is a specialty vaccine company focused on the development and commercialization of prophylactic vaccines for infectious diseases with significant unmet medical needs. Valneva has leveraged its expertise and capabilities both to successfully commercialize two vaccines and to rapidly advance a broad range of vaccine candidates into and through the clinic, including candidates against Lyme disease, the chikungunya virus, and COVID-19.
Number of employees
500-1000
Headquarters
Saint-herblain, Pays de la Loire, France